Alan Bentley

Vanderbilt tech transfer sets records: $86.7M in licensing revenue in FY22 ranks sixth-highest nationally, and $96M in licensing revenue in FY23 is largest in university history. Revamped processes in the Center for Technology Transfer and Commercialization makes licensing and launching new ventures faster and easier than ever before. Read More

The inaugural Life Science Showcase highlighted recent successes and opportunities to spur growth in state-of-the-art research across small molecules, vaccines, antibodies, medical devices in development and more. The July 19 event brought together leaders in academia and industry on Vanderbilt University’s campus. Read More

Seed and Series A funding to three startups—HeroWear, IDBiologics and Virtuoso—rooted in research conducted at Vanderbilt University and Vanderbilt University Medical Center underscore a university-wide commitment to enhanced support for Vanderbilt’s most innovative faculty, students and alumni. Read More

With the new partnership, LaunchTN and Vanderbilt will work collaboratively to support, engage and attract high-growth startups. Read More

The Vanderbilt Center for Technology Transfer and Commercialization generated more than $100 million in licensing revenue—quadruple its annual average—and reviewed more than 1,000 material transfer agreements and facilitated nearly 300 U.S. patent applications in the 2022 fiscal year. Read More

Vanderbilt University ranks 35th on the list of the top 100 worldwide universities granted U.S. utility patents in 2020. This is up one spot from 2019. Read More

The Center for Technology Transfer and Commercialization continued to play a pivotal role in translating the research findings of Vanderbilt faculty into products and companies in 2020 that have the potential to transform many aspects of life, from disease prevention to quality of life-enhancing products. Read More

A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Read More

To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time. Read More

Vanderbilt University—for the second consecutive year—has been named the 10th most innovative university in the world, according to a 2018 "Reuters Top 100" analysis. Read More

How can we — together — make research at Vanderbilt University Medical Center (VUMC) better and stronger? Read More

The SEC Network will provide coverage of the 2015 SEC Symposium, highlighted by a live SEC Network+ stream of the student entrepreneurial pitch competition on Monday, Sept. 21. Read More

Vanderbilt faculty will join colleagues from the other 13 Southeastern Conference universities for a symposium titled “Creativity, Innovation and Entrepreneurship: Driving a 21st-Century Economy” Sept. 20-22 in Atlanta. Read More

Vanderbilt signed 101 licensing agreements with industry partners during fiscal year 2014, nearly 20 more than the record total set last year. Many transactions were in medical diagnostics, health care information technology, pharmaceutics, oncology and biotechnology. Read More

Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year. Read More

Vanderbilt University Medical Center has launched an automated system for processing and managing Material Transfer Agreements (MTAs), which govern the transfer of biological materials, chemicals, human tissue samples and other materials between institutions to facilitate academic research. Read More

Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced. Read More

A wireless electrocardiogram (ECG) invented at Vanderbilt University is the centerpiece of a startup company that has been chosen to be a part of the Jumpstart Foundry Class of 2013. Read More

Last month, Vanderbilt University announced a collaboration agreement with GlaxoSmithKline, a leading pharmaceutical and consumer health care company, to develop potential new drugs for severe obesity. Read More

The annual Thomas A. Hazinski Faculty Development Workshop this year centers on the encouragement of innovation. The two main speakers — David Owens, Ph.D., professor of Practice of Management and Innovation at the Owen Graduate School of Management, and Alan Bentley, M.S., assistant vice… Read More